For the treatment of obesity, GLP-1RAs and GIP/ GLP-1RAs are indicated in patients with a body mass index (BMI) 30 kg m 2 , or 27 kg m 2 in the presence of at least one weight-related comorbidity, to support weight reduction [23]
However, randomized clinical trials examining the efficacy of the medications for weight loss were not designed to capture rare gastrointestinal events due to their small sample sizes and short follow-up periods
If you skipped a dose because of vomiting, dehydration, or an acute illness, thats a legitimate reason and your clinician will probably agree with the decision
Published Literature on Combined Peptide Protocols While dedicated head-to-head or combination human clinical trials are not yet available, a growing body of pre-clinical rodent research supports the mechanistic basis for studying these peptides together
The standard preparation is 3 mL of bacteriostatic water added to a 10 mg vial, producing a 3.33 mg/mL solution
Williams and Asif Nawaz contributed equally